Report - Business Strategy Section › e › ir › annual › pdf › CR_2017_en_04.pdf · OTC drugs ¥3.4 billion Others ¥1.4 billion Revenue (FY 2016) ¥ 423.9 billion 74.1% 0.3% % ...

Please pass captcha verification before submit form